Eledon Pharmaceuticals, Inc.
ELDN· Nasdaq
Released Aug 6, 2018, after the close
10-Q filed Aug 7, 2018, 38 days after period end · 0001564590-18-019519
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Revenue | — | — | $0.00 | $0.00 |
| Net Income | -$3.19M | -$6.66M | -$1.00M | -$8.96M |
| EPS Diluted |
Eledon Pharmaceuticals, Inc. · CIK 1404281 · Engraved from SEC EDGAR
| -$0.34 |
| -$1.32 |
| -$2.25 |
| -$0.40 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.